http://www.fpnotebook.com/
Diabetic NephropathyAka: Nephropathy of Diabetes Mellitus
- Pathophysiology: Nephropathy progression
- Step 1: Incipient Nephropathy phase
- Microalbuminuria (low levels of albumin) present
- Urine Albumin levels gradually rise during this phase
- Step 2: Overt Nephropathy phase
- Urine Albumin >300 mg/24 hours
- Hyperfiltration transiently occurs
- Glomerular filtration (Creatinine Clearance) rises
- Step 3: Renal Insufficiency
- Glomerular filtration (Creatinine Clearance) falls
- Ultimately Renal Failure ensues
- Step 1: Incipient Nephropathy phase
- Monitoring
- Monitor for Microalbuminuria every 6-12 months
- Initiating monitoring
- Type I Diabetes Mellitus: 5 years after diagnosis
- Type II Diabetes Mellitus: Start at time of diagnosis
- Labs: Urine Protein
- General
- Nephropathy diagnosis needs 2 of 3 samples positive
- Normal
- 24h Collection: <30 mg/day
- Timed Collection: <20 ug/min
- Spot Collection: <30 ug/mg Creatinine
- Microalbuminuria
- 24h Collection: 30-300 mg/day
- Timed Collection: 20-200 ug/min
- Spot Collection: 30-300 ug/mg Creatinine
- Clinical albuminuria
- 24h Collection: >300 mg/day
- Timed Collection: >200 ug/min
- Spot Collection: >300 ug/mg Creatinine
- General
- Management
- Tight glycemic control
- Keep Hemoglobin A1C <7%
- Better glycemic control reduces nephropathy risk
- Microalbuminuria risk with Hemoglobin A1C > 8.1%
- Krolewski (1995) N Engl J Med 332(19):1251
- Control Hyperlipidemia
- Control Hypertension
- Antihypertensives
- ACE Inhibitors (preferred)
- Angiotensin Receptor Blockers (ARB)
- Also slows nephropathy progression
- Lewis (2001) N Engl J Med 345:851
- Non-Dihydropyridine Calcium Channel Blockers
- Example: Diltiazem
- Reduces Proteinuria (less than ACE Inhibitor)
- Avoid Dihydropyridine Calcium Channel Blockers
- Nifedipine, Amlodipine may increase Proteinuria
- Hypertension goals
- Keep Blood Pressure under 130/80
- Isolated Systolic Hypertension goals
- Keep Systolic Blood Pressure under 140
- Antihypertensives
- Tight glycemic control
- Management: Dietary changes (incomplete evidence)
- Dietary modification: CR-LIPE
- Better than protein restriction in retarding CRI
- Components
- 50% carbohydrate restricted (CR)
- Low Iron available (LI)
- Polyphenol enriched (PE)
- References
- Protein restriction
- Near Normal GFR: <0.8g/kg/day Protein
- Falling GFR: <0.6g/kg/day Protein
- Dietary modification: CR-LIPE
- Referral to Nephrology Indications
- Serum Creatinine over 2.0 mg/dl
- Glomerular Filtration Rate (GFR) less than 70 ml/min
- Prognosis
- Dialysis usually needed when GFR reaches 10 ml/min
- GFR decline after onset microalbuminuria
- No ACE Inhibitor: 10 ml/min/year
- ACE Inhibitor: 4-6 ml/min/year
- References
Diabetic Nephropathy (C0011881) | |
|---|---|
| Definition (MSH) | KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. |
| Definition (CSP) | kidney disease and resultant kidney function impairment due to the long standing effects of diabetes on the microvasculature (glomerulus) of the kidney; features include increased urine protein and declining kidney function. |
| Concepts | Disease or Syndrome (T047) |
| ICD9 | 250.4 |
| MSH | D003928 |
| English | Diabetes + nephropathy, Diabetes with renal manifestations, Diabetes-nephrosis syndrome, Diabetic Kidney Disease, Diabetic Kidney Diseases, Diabetic Kidney Problems, Diabetic Nephropathies, Diabetic Nephropathy, Diabetic renal disease, Nephropathy - diabetic, Nephrotic syndrome in diabetes mellitus, Renal disorder associated with diabetes mellitus |
| Spanish | diabetes con manifestaciones renales, enfermedad renal diabetica, nefropatia diabetica, sindrome de diabetes - nefrosis, sindrome nefrotico en diabetes mellitus, trastorno renal asociado con diabetes mellitus |
| Parent Concepts | Complications of Diabetes Mellitus (C0342257), Diabetes Mellitus (C0011849), Kidney Diseases (C0022658), Diabetic Nephropathy (C0011881), Diabetic complications (C0271672), Renal disorders in systemic disease (C0403517), Ambiguous concept (C1274012) |
| Sources | CCS, COSTAR, CSP, ICD9CM, LCH, MEDLINEPLUS, MSH, MTH, NDFRT, QMR, SCTSPA, SNOMEDCT Derived from the NIH UMLS (Unified Medical Language System) |